Andrew Paul Feinberg

Andrew Paul Feinberg
Born(1952-08-05)August 5, 1952
Education
Known forcancer epigenetics
Scientific career
Workplaces

Andrew Paul Feinberg (born August 5, 1952) is the director of the Center for Epigenetics, chief of the Division of Molecular Medicine in the Department of Medicine, and the King Fahd Professor of Medicine, Oncology, and Molecular Biology & Genetics in the School of Medicine at Johns Hopkins University. He is the Bloomberg Distinguished Professor of Epigenetics. He holds appointments in the Departments of Medicine, Oncology, Molecular Biology & Genetics, and Psychiatry & Behavioral Sciences in the School of Medicine; in the Departments of Mental Health and Biostatistics in the Bloomberg School of Public Health; and in the Department of Biomedical Engineering in the Whiting School of Engineering.

Feinberg is known for research on the role of epigenetic alterations in cancer, including the identification of widespread DNA methylation abnormalities and the role of genomic imprinting in tumor development. Feinberg’s research demonstrated that large-scale epigenomic alterations—including global DNA hypomethylation and partially methylated domains—contribute to tumor initiation, progression, and cellular heterogeneity. This work contributed to the development of the concept of epigenetic plasticity as a driver of cancer evolution. Feinberg's research has contributed to understanding the role of the epigenome as a central driver of cancer biology, identified causal epigenetic mechanisms for cancer risk and progression, and foundations for new approaches to cancer detection, prevention, and therapeutic intervention. He has also studied the epigenetics of common disease generally, with applications to metabolic, immunologic, and neuropsychiatric disease, and the integration of genetic risk with environmental exposure through the epigenome.